Authors

ASH Interview Series

The December issue of Oncology & Biotech News featured highlights from the 51st American Society of Hematology (ASH) Annual Meeting and Exposition. We wrap up our ASH coverage this month with interviews on multiple myeloma with Brian G.M. Durie, MD, medical director and co-founder of the International Myeloma Foundation; chronic lymphocytic leukemia (CLL) with Robert J. Kreitman, MD, from the National Cancer Institute; and chronic myeloid leukemia (CML) with Francis J. Giles, MD, Cancer Therapy and Research Center at The University of Texas Health Science Center in San Antonio.

Never too old for statins

Elderly patients with a history of an acute coronary syndrome (ACS) are at higher risk for subsequent cardiovascular events than younger patients.

Can Red Meat be Part of a Healthy Diet?

Over the past four decades, red meat has gotten a bad rap. Consumption of beef, pork, and lamb has been linked with poor cholesterol scores and increased risk of breast, colon, and rectal cancers as well as diabetes and a host of other chronic diseases. The conventional wisdom has, however, lumped all red meats into a single group and arrived at a blanket judgment that eating any red meat is equally harmful.

Effect of Rate Control on QOL in Patient With Permanent AF

Contemporary cardiac imaging in hypertrophic obstructive cardiomyopathy

Features of hypertrophic obstructive cardiomyopathy (HOCM) include obstruction at the left ventricular outflow tract (caused by a markedly thickened proximal interventricular septum) and systolic anterior motion of the mitral valve. The case discussed here illustrates several classic features of this disease including clinical presentation, diagnostic workup, and noninvasive and invasive management.

Can reduction in electrocardiographic left ventricular hypertrophy be helpful in preventing clinical heart failure?

As clinical cardiologists, we face an ever-changing landscape with regard to the management and care of hypertensive patients.

Obesity-related hypertension

To evaluate the interactions between the weight loss drug, sibutramine, and different antihypertensive treatments, we randomly assigned 171 subjects taking 3 antihypertensive treatment regimens to receive sibutramine or placebo. Our study showed for the first time that combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker is more advantageous than a ß blocker/diuretic-based-regimen with regard to supporting the weight-reducing actions and metabolic changes induced by sibutramine.

Why Online Social Networking Should Change What We Know about Health Care

Rather than being a force for depersonalizing medicine and driving a wedge between patients and physicians, it turns out that information technology and social media offer new opportunities for deeper communication and interaction.

Quality of Care and Outcome in Critical Access Rural Hospitals

What is the Role of Surgery in the Management of Patients with Diabetes?

Several studies have shown good results with Roux-en-Y gastric bypass and laparoscopic gastric banding when combined with lifestyle modifications in severely overweight patients with type 2 diabetes.

Know Your Enemy-A Brief History of Alternative Medicine

An idiosyncratic romp through the history of organized medicine

Moderna, Pfizer COVID-19 Vaccines Do Not Affect Male Fertility

The vaccines did not result in reductions in semen volume, sperm concentration, sperm motility, and total motile sperm count.

Metadata: An Orwellian Big Brother within Electronic Medical Records

Consider this hypothetical situation: A patient with new onset of a major depression is evaluated by a physician who has found no evidence of suicidal ideation.